TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Martek Biosciences Corp. Investor Files Lawsuit Against Buyout By Royal DMS N.V.

  • If you purchased shares of Martek Biosciences Corp. (NASDAQ:MATK) prior to Dec. 21 2010 and continue to hold those MATK shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

An investor in MATK filed a lawsuit in State Court against directors of Martek Biosciences Corp. for allegedly breaching their fiduciary duty arising out of their attempt to sell Martek Biosciences too cheaply via an unfair process to Royal DSM N.V. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties in connection with the transaction ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: